atovaquone

Generic: atovaquone

Labeler: a2a integrated pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name atovaquone
Generic Name atovaquone
Labeler a2a integrated pharmaceuticals, llc
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

atovaquone 750 mg/5mL

Manufacturer
A2A Integrated Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 73141-104
Product ID 73141-104_2abada7d-4115-54ca-e063-6394a90a3d4f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212918
Listing Expiration 2026-12-31
Marketing Start 2024-11-29

Pharmacologic Class

Established (EPC)
antimalarial [epc] antiprotozoal [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 73141104
Hyphenated Format 73141-104

Supplemental Identifiers

RxCUI
308429
UNII
Y883P1Z2LT
NUI
N0000175482 N0000175485

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name atovaquone (source: ndc)
Generic Name atovaquone (source: ndc)
Application Number ANDA212918 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 750 mg/5mL
source: ndc
Packaging
  • 42 CUP, UNIT-DOSE in 1 CARTON (73141-104-42) / 5 mL in 1 CUP, UNIT-DOSE (73141-104-05)
source: ndc

Packages (1)

73141-104-42 42 CUP, UNIT-DOSE in 1 CARTON (73141-104-42) / 5 mL in 1 CUP, UNIT-DOSE (73141-104-05)

Ingredients (1)

atovaquone (750 mg/5mL)

Linked Drug Pages (1)

Atovaquone ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2abada7d-4115-54ca-e063-6394a90a3d4f", "openfda": {"nui": ["N0000175482", "N0000175485"], "unii": ["Y883P1Z2LT"], "rxcui": ["308429"], "spl_set_id": ["27d64592-5078-6122-e063-6394a90ae074"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["A2A Integrated Pharmaceuticals, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "42 CUP, UNIT-DOSE in 1 CARTON (73141-104-42)  / 5 mL in 1 CUP, UNIT-DOSE (73141-104-05)", "package_ndc": "73141-104-42", "marketing_start_date": "20241129"}], "brand_name": "Atovaquone", "product_id": "73141-104_2abada7d-4115-54ca-e063-6394a90a3d4f", "dosage_form": "SUSPENSION", "pharm_class": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "product_ndc": "73141-104", "generic_name": "Atovaquone", "labeler_name": "A2A Integrated Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atovaquone", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "750 mg/5mL"}], "application_number": "ANDA212918", "marketing_category": "ANDA", "marketing_start_date": "20241129", "listing_expiration_date": "20261231"}